Thomas E. Shelton
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 8
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 3
-
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 2
- T-cell and B-cell Immunology 1
- Co-authors
- Steven A. RosenbergMark E. DudleyJohn R. WunderlichJos EvenPaul F. RobbinsMichelle M. LanghanStephanie L. GoffZhili Zheng
- Journals
- Journal of Immunotherapy (3 papers)Human Gene Therapy (1 paper)Clinical Cancer Research (1 paper)Archives of Biochemistry and Biophysics (1 paper)Nature Medicine (1 paper)
- Partner nations
- United StatesMalaysia
In The Last Decade
Thomas E. Shelton
8 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Immunology 1.2k
- Oncology 1.4k
- Genetics 282
- Biotechnology 52
- Molecular Biology 359
Countries citing papers authored by Thomas E. Shelton
This map shows the geographic impact of Thomas E. Shelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Shelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Shelton more than expected).
Fields of papers citing papers by Thomas E. Shelton
This network shows the impact of papers produced by Thomas E. Shelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Shelton. The network helps show where Thomas E. Shelton may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Shelton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 72 | |
| 2 | 2019 | 105 | |
| 3 | Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer Hit paper breakdown → | 2018 | 544 |
| 4 | 2018 | 45 | |
| 5 | 2008 | 210 | |
| 6 | 2008 | 117 | |
| 7 | Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients Hit paper breakdown → | 2003 | 534 |
| 8 | 2000 | 8 |
About Thomas E. Shelton
Thomas E. Shelton is a scholar working on Oncology, Immunology, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 1.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (2 papers), Protein Tyrosine Phosphatases (1 paper), Virus-based gene therapy research (1 paper), Cancer Genomics and Diagnostics (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.4k citations), Genetics (282 citations), Biotechnology (52 citations) and Molecular Biology (359 citations). Thomas E. Shelton has collaborated with scholars based in United States and Malaysia. Frequent co-authors include Steven A. Rosenberg, Mark E. Dudley, John R. Wunderlich, Jos Even, Paul F. Robbins, Michelle M. Langhan, Stephanie L. Goff, Zhili Zheng, Lee Jia and Yong‐Chen Lu. Their work appears in journals such as Journal of Immunotherapy, Human Gene Therapy, Clinical Cancer Research, Archives of Biochemistry and Biophysics and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.